Percentage of Time in Range 70 to 139 mg/dL Is Associated With Reduced Mortality Among Critically Ill Patients Receiving IV Insulin Infusion

Abstract

Listen

Translate article

In addition to hyperglycemia, hypoglycemia, and glycemic variability, reduced time in targeted blood glucose range (TIR) is associated with increased risk of death in critically ill patients. This relation between TIR and mortality may be confounded by diabetic status and antecedent glycemic control. This study retrospectively analyzed critically ill patients managed with the same IV insulin protocol at multiple centers. The percentage of TIR between 70 and 139mg/dL was calculated. Patients with diabetic ketoacidosis, patients who had< 10 blood glucose readings, and patients with repeat admissions were excluded. The highest recorded glycosylated hemoglobin value in the preceding 3months or up to 1month following admission were used as a surrogate for the patient's preexisting glucose control. Stratified regression analyses were performed for 30-day mortality, with covariates of age, sex, TIR ≥ 80%, Acute Physiology Score, and Charlson Comorbidity Index. A total of 9,028 patients, 53.2%of whom had diabetes, were studied. Median TIR was 84.1%for nondiabetic patients and 64.5%for patients with diabetes. Mortality was lower in those with TIR> 80%compared with those with TIR≤ 80%(12.4%vs19.2%; P< .001). TIR> 80%was independently associated with reduced mortality in nondiabetic patients (OR, 0.52; P< .001), patients with diabetes (OR, 0.69; P= .001), and patients with well-controlled disease (OR, 0.50; P< .001) but not in patients with poorly controlled disease (OR, 0.86; P= .40). TIR was independently associated with mortality in critically ill patients, particularly those with good antecedent glucose control.